We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.52B
AUM Growth
-$2.44B
Cap. Flow
-$2.44B
Cap. Flow %
-44.19%
Top 10 Hldgs %
51.97%
Holding
165
New
38
Increased
22
Reduced
40
Closed
65

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$420M
2
TRP icon
TC Energy
TRP
+$318M
3
CF icon
CF Industries
CF
+$203M
4
BABA icon
Alibaba
BABA
+$129M
5
PXD
Pioneer Natural Resource Co.
PXD
+$129M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$504M
2
WBA
Walgreens Boots Alliance
WBA
+$478M
3
VLO icon
Valero Energy
VLO
+$244M
4
HCA icon
HCA Healthcare
HCA
+$241M
5
WMB icon
Williams Companies
WMB
+$181M

Sector Composition

Rank Sector Weight
1 Healthcare 28.63%
2 Energy 26.23%
3 Materials 9.07%
4 Consumer Discretionary 7.49%
5 Technology 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APC
151
DELISTED
Anadarko Petroleum
APC
– –
-75,200
Closed -$8.23M
TFCFA
152
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
– –
-682,776
Closed -$24M
ANDV
153
DELISTED
Andeavor
ANDV
– –
-378,700
Closed -$22.2M
MON
154
DELISTED
Monsanto Co
MON
– –
-315,100
Closed -$39.3M
BEAV
155
DELISTED
B/E Aerospace Inc
BEAV
– –
-581,401
Closed -$38.9M
DYAX
156
DELISTED
DYAX CORPORATION
DYAX
– –
-500,000
Closed -$4.8M
HUB.B
157
DELISTED
HUBBELL INC CL-B
HUB.B
– –
-20,400
Closed -$2.51M
SLXP
158
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-100,000
Closed -$12.3M
COV
159
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-200,000
Closed -$18M
ATVI
160
DELISTED
Activision Blizzard
ATVI
– –
-191,700
Closed -$4.28M
SHPG
161
DELISTED
Shire pic
SHPG
– –
-43,293
Closed -$10.2M
SCTY
162
DELISTED
SolarCity Corporation
SCTY
– –
-449,500
Closed -$31.7M
QIHU
163
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
– –
-17,300
Closed -$1.59M
AGN
164
DELISTED
Allergan Inc
AGN
– –
-231,000
Closed -$39.1M
CZR
165
DELISTED
Caesars Entertainment Corporation
CZR
– –
-789,300
Closed -$14.3M
3 4 5 6
7

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q3 2014 Portfolio in Review

As of Q3 2014, PointState Capital held 165 positions worth $5.52B, down 31% from $7.96B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

PointState Capital withdrew a net $2.44B in Q3 2014, closing 65 positions and reducing 40 holdings. Its most notable exit was Paramount Global Class B, an estimated $504M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Energy and Materials.

Against the trend, PointState Capital opened a new position in AbbVie worth $437M.

  • PointState Capital's largest Q3 2014 buy was AbbVie: 7,568,600 shares worth $437M.
  • PointState Capital added most to CF Industries in Q3 2014, an estimated $203M increase.
  • PointState Capital's biggest Q3 2014 reduction was Walgreens Boots Alliance, cutting an estimated $478M.
  • PointState Capital fully exited Paramount Global Class B in Q3 2014, selling an estimated $504M.
  • PointState Capital's ten largest holdings make up 52% of its $5.52B portfolio in Q3 2014.
  • PointState Capital opened 38 new positions and closed 65 in Q3 2014.
  • PointState Capital's portfolio value fell 31% quarter-over-quarter to $5.52B.

Based on PointState Capital's 13F filing for Q3 2014, filed 14 Nov 2014.